2025. Half-life-extended monoclonal antibody APG777 for atopic dermatitis: Design of the phase 2 APEX study. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s550. DOI:https://doi.org/10.25251/skin.10.supp.550.